Melanoma-Prone Families With CDKN2A Mutations Have Higher Rates of Additional Cancers

Share this content:
Melanoma-Prone Families With CDKN2A Mutations Have Higher Rates of Additional Cancers
Melanoma-Prone Families With CDKN2A Mutations Have Higher Rates of Additional Cancers
Researchers discovered an increased prevalence of lung, pancreatic and breast cancer in families prone to melanoma who also carry CDKN2A germline mutations. In a cross-sectional study, researchers analyzed the effect of CDKN2A in 702 Spanish patients at high risk of developing melanoma and associations with clinical and family history features.
READ FULL ARTICLE From HealIO
Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


is free, fast, and customized just for you!

Already a member?

Sign In Now »